Wet Weight Determination of Mammary Gland Tissue in Mouse Models of Mastitis: Principles, Methods, a

Wet weight determination of mammary gland tissue is a fundamental quantitative endpoint for assessing inflammatory edema in mouse models of mastitis. This simple yet sensitive measurement provides researchers with objective data on disease severity and therapeutic efficacy, making it an essential component of preclinical anti-inflammatory studies. This article describes the technical principles, sample handling requirements, measurement procedures, and typical applications of mammary gland wet weight determination in experimental mastitis research.

Technical Overview

Mastitis, the inflammation of mammary gland tissue, is commonly modeled in mice through intramammary inoculation of lipopolysaccharide (LPS) from Escherichia coli or suspensions of Staphylococcus aureus. Following induction, the gland undergoes a cascade of pathological changes including hyperemia, vascular leakage, interstitial edema, and massive infiltration of neutrophils and macrophages. These changes collectively manifest as a measurable increase in gland mass.

Mammary gland wet weight determination quantifies this mass increase and serves as a direct, reproducible index of inflammatory severity. In a typical study design, wet weight is reported as an absolute value (mg) and as a normalized ratio relative to body weight (mg/g), which corrects for inter-animal variation. When mastitis is successfully induced, the affected gland typically shows a significant elevation in wet weight compared with the sham or control group, and therapeutic interventions that suppress inflammation are expected to attenuate this increase.

The method is valued for its simplicity, speed, and compatibility with parallel analyses such as histopathology, myeloperoxidase (MPO) activity assays, and cytokine quantification. When performed under standardized conditions in accredited third-party laboratories or institutional preclinical research facilities, wet weight determination delivers reliable data suitable for publication, regulatory submission support, and internal decision-making.

Testing Samples

Inguinal Mammary Glands (Fourth Pair)

The inguinal (abdominal) mammary glands are the most frequently collected samples in mouse mastitis studies. Because LPS or bacterial inoculation is typically administered through the teat canal of the fourth mammary gland pair, these glands are large enough for accurate weighing, easy to dissect cleanly, and directly aligned with the inoculation site. Each mouse yields a paired left and right gland, enabling flexible experimental allocation.

Thoracic Mammary Glands (Second and Third Pairs)

Thoracic glands may be collected in studies examining systemic or multi-gland inflammatory responses. They are smaller than inguinal glands and require more meticulous dissection to remove adherent fat and pectoral muscle tissue without damaging the parenchyma.

Contralateral Gland Allocation

A common and statistically efficient design uses the two glands of each mouse for different endpoints: one gland is designated for immediate wet weight determination, while the contralateral gland is fixed in formalin for histopathology, snap-frozen for cytokine assays (TNF-α, IL-1β, IL-6), or processed for Western blot and qPCR analysis of inflammatory signaling pathways such as TLR4/NF-κB.

Testing Items

The core deliverables of a mammary gland wet weight determination study include the following quantitative parameters:

• Absolute wet weight of the dissected mammary gland, recorded in milligrams (mg) using a calibrated analytical balance.
• Wet weight to body weight ratio (mg/g), calculated to normalize for differences in animal size across groups.
• Mammary gland organ index (%), expressed as gland wet weight divided by body weight multiplied by 100.
• Wet weight to dry weight ratio, optionally determined by drying the same gland to constant mass, providing a tissue water content (edema index) value.
• Between-group statistical comparison of all parameters, typically presented as mean ± SEM with analysis of variance (ANOVA) followed by appropriate post hoc tests.

Testing Methods

Sample Collection and Dissection

At the designated endpoint, mice are euthanized according to approved institutional animal care protocols consistent with the principles of the Guide for the Care and Use of Laboratory Animals and applicable national standards such as GB 14925 for laboratory animal management. The mammary gland is exposed by careful skin reflection, dissected free from the underlying abdominal wall, and trimmed of surrounding adipose tissue, connective tissue, and lymph nodes using fine surgical instruments. Consistency in trimming technique is critical, because retained fat or connective tissue introduces systematic bias in wet weight values.

Weighing Procedure

Immediately after dissection, the gland is gently blotted on standardized filter paper to remove surface blood and exudate without compressing the tissue. Excess blotting can express interstitial fluid and artificially lower the weight, while insufficient blotting leaves surface moisture that inflates it. The sample is then placed on a tared analytical balance with a readability of 0.1 mg, and the weight is recorded without delay. Key standardization requirements include:

• Use of a calibrated analytical balance (0.1 mg readability) with periodic verification traceable to recognized metrology standards.
• A uniform and minimized interval between euthanasia, dissection, blotting, and weighing to prevent evaporative mass loss.
• Consistent blotting pressure and contact time applied by a single trained operator whenever feasible.
• Recording of ambient conditions, since prolonged exposure to laboratory air causes progressive tissue desiccation.
• Blinded weighing, in which the operator is unaware of group allocation, to eliminate observer bias.

Data Processing and Statistical Analysis

Raw wet weight values are entered into a validated data template alongside animal body weight, group code, and inoculation details. Normalized indices are computed, outliers are evaluated against pre-defined exclusion criteria, and group means are compared using one-way ANOVA with Tukey or Dunnett post hoc tests, or non-parametric equivalents where normality assumptions are not met. A reduction in mammary wet weight in treated groups relative to the untreated mastitis model group is interpreted as evidence of anti-edema and anti-inflammatory activity. Studies conducted in accredited third-party laboratories operating under an ISO/IEC 17025-aligned quality system provide additional assurance of data integrity, equipment calibration, and method validation.

Quality Control Considerations

• Verification of mastitis induction in a sentinel subset of animals by clinical signs, histopathology, or MPO activity before committing the full cohort.
• Randomization of sample processing order to distribute any time-dependent drift equally across groups.
• Documentation of dissection time, operator identity, and balance identification for each sample.
• Use of paired-gland designs to reduce biological variability and improve statistical power.
• Adherence to ARRIVE reporting guidelines for animal studies to ensure transparency of methods and results.

Applications

Mammary gland wet weight determination supports a broad range of preclinical research and development activities:

• Anti-mastitis drug screening: Quantitative evaluation of antibiotics, anti-inflammatory agents, natural products, and plant-derived compounds in LPS-induced or S. aureus-induced mastitis models.
• Traditional medicine research: Objective efficacy assessment of herbal extracts and formulated preparations using inflammatory edema as a primary endpoint.
• Mechanistic studies: Correlation of wet weight changes with histopathological scores, cytokine profiles, and signaling pathway markers to elucidate anti-inflammatory mechanisms.
• Nutritional and immunological research: Evaluation of dietary supplements, probiotics, and immunomodulators on mammary gland health during lactation challenge models.
• Preclinical efficacy packages: Generation of reproducible endpoint data in CRO or accredited third-party laboratory settings to support internal development decisions and publication.

FAQ

Why does mammary gland wet weight increase in mastitis model mice?

Inflammatory stimuli trigger vasodilation, increased vascular permeability, and interstitial fluid accumulation, together with neutrophil and macrophage infiltration. The sum of these changes is tissue edema and cellular influx, both of which add measurable mass to the gland.

What balance precision is required for reliable results?

An analytical balance with 0.1 mg readability is recommended. Mouse mammary glands typically weigh in the range of tens to a few hundred milligrams, so milligram-level resolution is necessary to detect biologically meaningful between-group differences.

How quickly must the tissue be weighed after collection?

Weighing should be completed within minutes of dissection. Tissue loses moisture continuously to the atmosphere, and any delay introduces systematic downward bias that varies with handling time.

Can wet weight be combined with other endpoints from the same animal?

Yes. The paired-gland design allows one gland to be weighed while the contralateral gland is used for histology, cytokine assays, or molecular analysis, enabling robust within-animal correlation of inflammatory indices.

What does the wet weight to dry weight ratio add to the analysis?

By drying the gland to constant mass, the water content can be calculated. This edema index distinguishes fluid accumulation from cellular infiltration as the driver of weight gain, providing deeper mechanistic insight into anti-inflammatory treatment effects.

Are there reporting standards for these animal studies?

Studies should comply with institutional animal care and use committee approvals, national laboratory animal standards such as GB 14925, and be reported in accordance with ARRIVE guidelines. Laboratories following ISO/IEC 17025-aligned quality management systems ensure calibrated equipment, validated procedures, and traceable records.